Abstract
Time to Follow the Evidence: Glycemic Control and Cardiovascular Benefits of New Diabetes Medications
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.amjmed.2020.12.012
Copy DOIJournal: The American Journal of Medicine | Publication Date: Jan 9, 2021 |
Citations: 3 |
Time to Follow the Evidence: Glycemic Control and Cardiovascular Benefits of New Diabetes Medications
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.